IPO registrations (S-1, F-1) · Registrants

RIGEL PHARMACEUTICALS INC

SEC CIK
1034842 · filings on EDGAR ↗
Registration
Form S-1, first filed 2000-02-04, last 2000-11-22; 2 initial registrations, 9 amendments
Outcome
Final prospectus filed 2000-11-29; withdrawal requested 2000-04-13
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
611 GATEWAY BOULEVARD, SUITE 900, South San Francisco, CA 94080
EIN
94-3248524
Ticker
RIGL (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
RIGEL PHARMACEUTICALS INC on the corporate pages

Offering terms

Proposed price range
$7.00–$8.00 per share (S-1/A filed 2000-11-22)
Final price
$7.00 per share, within the range (424B4 filed 2000-11-29, an initial public offering)
Shares sold
5,000,000
Gross proceeds
$35,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol RIGL
Lead underwriters
Morgan Stanley; Lehman Brothers (1,083,400 shares); Robertson Stephens (1,083,400 shares)
Syndicate
William Blair (83,300); RBC Capital Markets (83,300); Wachovia (83,300); Janney Montgomery Scott (83,300); Edward D. Jones & Co., L.P (83,300); Needham & Company (83,300); UBS (83,300)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 13

FiledFormWhat it isName as filedEDGAR
2000-02-04S-1S-1 (registration)RIGEL PHARMACEUTICALS INC0000912057-00-003828 ↗
2000-03-08S-1/AS-1/A (amendment)RIGEL PHARMACEUTICALS INC0000912057-00-010469 ↗
2000-03-24S-1/AS-1/A (amendment)RIGEL PHARMACEUTICALS INC0000912057-00-013274 ↗
2000-03-24S-1/AS-1/A (amendment)RIGEL PHARMACEUTICALS INC0000912057-00-013488 ↗
2000-03-28S-1/AS-1/A (amendment)RIGEL PHARMACEUTICALS INC0000912057-00-013988 ↗
2000-04-11S-1/AS-1/A (amendment)RIGEL PHARMACEUTICALS INC0000912057-00-017467 ↗
2000-04-13RWRW (withdrawal request)RIGEL PHARMACEUTICALS INC0000912057-00-017932 ↗
2000-09-15S-1S-1 (registration)RIGEL PHARMACEUTICALS INC0000912057-00-041537 ↗
2000-10-02S-1/AS-1/A (amendment)RIGEL PHARMACEUTICALS INC0000912057-00-043386 ↗
2000-10-16S-1/AS-1/A (amendment)RIGEL PHARMACEUTICALS INC0000912057-00-044783 ↗
2000-11-17S-1/AS-1/A (amendment)RIGEL PHARMACEUTICALS INC0000912057-00-050782 ↗
2000-11-22S-1/AS-1/A (amendment)RIGEL PHARMACEUTICALS INC0000912057-00-051139 ↗
2000-11-29424B4424B4 (final prospectus)RIGEL PHARMACEUTICALS INC0000912057-00-051611 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2000-11-22S-1/Aregistration statement$7.00–$8.005,000,000-Nasdaq RIGL3primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 3document ↗
2000-11-29424B4final prospectus$7.005,000,000$35,000,000Nasdaq RIGL10primary document; price sentence, shares headline, proceeds computed, underwriting table 9, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
COOPER ROBIN D GOfficerSr. V.P. Pharmaceutical Scs.42006–2008
GOWER JAMES MDirector,OfficerCEO & Board Chairman102006–2014
GROSSBARD ELLIOT BOfficerEVP, CMO; Sr. VP Medical Development132006–2016
PAYAN DONALD GDirector,OfficerEVP, Pres. Discovery&Research; Ex. VP Chief Sci. Officer192006–2016
RODRIGUEZ RAUL RDirector,Officer; OfficerCEO, President; EVP, COO; President & COO482006–2026
VANCE DOLLYOfficerEVP Corp. Affairs, G.C., Sect.; SVP, Gen. Counsel, Corp. Sec.; VP Intel. Prop.& Gen.Counsel302006–2022
WELCH JAMES HOfficerCFO, VP & Secretary12006
FRAZIER ALAN DDirector32006
LYONS GARY ADirector182006–2023
MOOS WALTER HDirector242006–2026
RENTON HOLLINGSDirector82006–2013
RINGROSE PETER SDirector132006–2018
DELEAGE JEANDirector62006–2010
SHERWIN STEPHEN ADirector122006–2016
Maynard Ryan DOfficerEVP & CFO; VP, CFO; VP Finance, Acting CFO212006–2017
Goodwin Bradford SDirector182007–2021
DEERFIELD CAPITAL LPTenPercentOwnerOther32010–2011
DEERFIELD INTERNATIONAL LTDTenPercentOwnerOther32010–2011
DEERFIELD MANAGEMENT CO /NYTenPercentOwnerOther32010–2011
DEERFIELD PARTNERS, LPTenPercentOwnerOther32010–2011
Deerfield Special Situations Fund International LTDTenPercentOwnerOther32010–2011
Deerfield Special Situations Fund, L.P.TenPercentOwnerOther32010–2011
Flynn James ETenPercentOwnerOther32010–2011person page Fuzzy
BIOTECHNOLOGY VALUE FUND II LPOther32013
BIOTECHNOLOGY VALUE FUND L POther32013
BVF INC/ILTenPercentOwner32013
BVF INVESTMENTS LLCOther32013
BVF PARTNERS L P/ILTenPercentOwner32013
INVESTMENT 10 LLCOther12013
LAMPERT MARK NTenPercentOwner32013
Katkin KeithDirector82015–2021
Duliege Anne-MarieOfficerChief Medical Officer; EVP & Chief Medical Officer132016–2019
Lasaga JosephOfficerSr.VP Bus.Dev.Alliance Mgmt.; VP Bus. Dev.& Alliance Mgmt.82016–2019
Masuda EstebanOfficerSr. VP Research72016–2019
Mayer Eldon C. IIIOfficerEVP & Chief Commercial Officer; EVP &Chief Commercial Officer102016–2019
Kotzin Brian L.Director92017–2024
LAPOINTE ANTHONY GREGGDirector112017–2026
Cabatuan NelsonOfficerPrincipal Accounting Officer; VP,Finance & Princ.Acctg. Off.72017–2020
Markel StacyOfficerEVP Human Resources42018–2019
Schorno Dean LOfficerEVP & Chief Financial Officer; EVP &Chief Financial Officer312018–2026
Wasman JaneDirector102019–2026
Dummer WolfgangOfficerChief Medical Officer; EVP & CMO82019–2023
Santos David AOfficerEVP, Chief Commercial Officer212020–2026
HANNAH ALISON L.Director; OfficerEVP, Chief Medical Officer92021–2026
Ali-Jackson KamilDirector92021–2026
Furey Raymond J.OfficerEVP, GC, CCO & Corp Sec; EVP, GC & Corp Sec132022–2026
Rojkjaer LisaOfficerEVP, Chief Medical Officer92024–2026
Frohlich Mark WDirector42025–2026
MILLER MICHAEL PATRICKDirector32026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationRigel Pharmaceuticals, Inc.CAState business registriesname and state
Business registrationRigel Pharmaceuticals, Inc.CAState business registriesname and state
Business registrationRigel Pharmaceuticals, Inc.CAState business registriesname and state
Business registrationRigel Pharmaceuticals, Inc.CAState business registriesname and state
Business registrationRIGEL PHARMACEUTICALS, Inc.CAState business registriesname and state
Business registrationRIGEL PHARMACEUTICALS INCCAState business registriesname and state
Business registrationRIGEL PHARMACEUTICALS INCCAState business registriesEIN (EXACT, as the state registration reports it)
Business registrationRIGEL PHARMACEUTICALS, INC.CAState business registriesname and state
Business registrationRIGEL PHARMACEUTICALS, INC.CAState business registriesname and state
Business registrationRIGEL PHARMACEUTICALS, INC.CAState business registriesname and state
Business registrationRIGEL PHARMACEUTICALS, INC.CAState business registriesname and state
Federal award recipientRIGEL PHARMACEUTICALS INCCAFederal spending (USAspending)name and state
Lobbying clientRIGEL PHARMACEUTICALS INC.CAFederal lobbying (LDA)name and state
Paying companyRigel Pharmaceuticals, Inc.CAOpen Payments (drug and device company payments)name and state
Patent assigneeRigel Pharmaceuticals, Inc.CAPatents (USPTO)name and state
SEC filerRIGEL PHARMACEUTICALS INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerRigel Pharmaceuticals, Inc.CATrademarks (USPTO)name and state
Form 5500 plan sponsorRIGEL PHARMACEUTICALS INC.EIN (EXACT)
Person pageJames E FlynnPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, CA first:

More with this interest.

In other datasets, the same topic (Health) in CA:

Interests: Pharmaceutical Preparations · Health